NM_005431.2:c.825T>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_005431.2(XRCC2):​c.825T>G​(p.Ser275Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000362 in 1,603,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S275N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

XRCC2
NM_005431.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.428

Publications

1 publications found
Variant links:
Genes affected
XRCC2 (HGNC:12829): (X-ray repair cross complementing 2) This gene encodes a member of the RecA/Rad51-related protein family that participates in homologous recombination to maintain chromosome stability and repair DNA damage. This gene is involved in the repair of DNA double-strand breaks by homologous recombination and it functionally complements Chinese hamster irs1, a repair-deficient mutant that exhibits hypersensitivity to a number of different DNA-damaging agents. [provided by RefSeq, Jul 2008]
XRCC2 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group U
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 17
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • spermatogenic failure 50
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10213509).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XRCC2NM_005431.2 linkc.825T>G p.Ser275Arg missense_variant Exon 3 of 3 ENST00000359321.2 NP_005422.1 O43543A0A384MEK2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XRCC2ENST00000359321.2 linkc.825T>G p.Ser275Arg missense_variant Exon 3 of 3 1 NM_005431.2 ENSP00000352271.1 O43543
XRCC2ENST00000495707.1 linkn.847T>G non_coding_transcript_exon_variant Exon 3 of 3 1
XRCC2ENST00000698506.1 linkc.657T>G p.Ser219Arg missense_variant Exon 2 of 2 ENSP00000513758.1 A0A8V8TMB7
ENSG00000298894ENST00000758786.1 linkn.254-12050A>C intron_variant Intron 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152108
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000909
AC:
22
AN:
242012
AF XY:
0.0000991
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000829
Gnomad NFE exome
AF:
0.0000362
Gnomad OTH exome
AF:
0.000170
GnomAD4 exome
AF:
0.0000344
AC:
50
AN:
1451522
Hom.:
0
Cov.:
31
AF XY:
0.0000402
AC XY:
29
AN XY:
721654
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33058
American (AMR)
AF:
0.00
AC:
0
AN:
43366
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25446
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39640
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84440
European-Finnish (FIN)
AF:
0.000708
AC:
37
AN:
52246
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5548
European-Non Finnish (NFE)
AF:
0.00000722
AC:
8
AN:
1107822
Other (OTH)
AF:
0.0000834
AC:
5
AN:
59956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152108
Hom.:
0
Cov.:
32
AF XY:
0.0000808
AC XY:
6
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41424
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group U;C5436888:Spermatogenic failure 50;C5436889:Premature ovarian failure 17 Uncertain:1
May 29, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
May 31, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt XRCC2 protein function. ClinVar contains an entry for this variant (Variation ID: 827540). This variant has not been reported in the literature in individuals affected with XRCC2-related conditions. This variant is present in population databases (rs770438650, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 275 of the XRCC2 protein (p.Ser275Arg). -

Hereditary cancer-predisposing syndrome Uncertain:1
Sep 13, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S275R variant (also known as c.825T>G), located in coding exon 3 of the XRCC2 gene, results from a T to G substitution at nucleotide position 825. The serine at codon 275 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.082
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
0.43
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.11
Sift
Benign
0.061
T
Sift4G
Benign
0.29
T
Polyphen
0.67
P
Vest4
0.21
MutPred
0.30
Gain of MoRF binding (P = 0.0668);
MVP
0.65
MPC
0.097
ClinPred
0.068
T
GERP RS
1.5
Varity_R
0.11
gMVP
0.26
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770438650; hg19: chr7-152345745; API